1. Home
  2. DNTH vs NAC Comparison

DNTH vs NAC Comparison

Compare DNTH & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • NAC
  • Stock Information
  • Founded
  • DNTH 2015
  • NAC 1998
  • Country
  • DNTH United States
  • NAC France
  • Employees
  • DNTH N/A
  • NAC N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • NAC Investment Managers
  • Sector
  • DNTH Health Care
  • NAC Finance
  • Exchange
  • DNTH Nasdaq
  • NAC Nasdaq
  • Market Cap
  • DNTH 1.4B
  • NAC 1.6B
  • IPO Year
  • DNTH N/A
  • NAC N/A
  • Fundamental
  • Price
  • DNTH $33.67
  • NAC $11.99
  • Analyst Decision
  • DNTH Strong Buy
  • NAC
  • Analyst Count
  • DNTH 11
  • NAC 0
  • Target Price
  • DNTH $65.22
  • NAC N/A
  • AVG Volume (30 Days)
  • DNTH 516.1K
  • NAC 307.3K
  • Earning Date
  • DNTH 11-07-2025
  • NAC 01-01-0001
  • Dividend Yield
  • DNTH N/A
  • NAC 4.33%
  • EPS Growth
  • DNTH N/A
  • NAC N/A
  • EPS
  • DNTH N/A
  • NAC N/A
  • Revenue
  • DNTH $4,854,000.00
  • NAC N/A
  • Revenue This Year
  • DNTH N/A
  • NAC N/A
  • Revenue Next Year
  • DNTH N/A
  • NAC N/A
  • P/E Ratio
  • DNTH N/A
  • NAC N/A
  • Revenue Growth
  • DNTH 17.87
  • NAC N/A
  • 52 Week Low
  • DNTH $13.37
  • NAC $9.32
  • 52 Week High
  • DNTH $40.16
  • NAC $11.21
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 46.99
  • NAC 77.43
  • Support Level
  • DNTH $32.28
  • NAC $11.81
  • Resistance Level
  • DNTH $35.40
  • NAC $11.89
  • Average True Range (ATR)
  • DNTH 1.59
  • NAC 0.08
  • MACD
  • DNTH -0.20
  • NAC 0.01
  • Stochastic Oscillator
  • DNTH 26.53
  • NAC 85.56

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About NAC Nuveen California Quality Municipal Income Fund

Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: